MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey

Journal of Rheumatology

Volumn 35, Issue 1, 2008, Pages 106-113

  Yigit, Serbulent ^a   Bagci, Hasan ^a   Ozkaya, Ozan ^a   Ozdamar, Kazim ^b   Cengiz, Kuddusi ^a   Akpolat, Tekin ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Amyloidosis; Black Sea region; Diagnosis; Familial Mediterranean fever; MEFV

Indexed keywords

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CHILD; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEFV GENE; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS, FAMILIAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; PHENOTYPE; POINT MUTATION; PROSPECTIVE STUDIES; TURKEY;

EID: 38149055646     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Tunca M, Akar S, Onen F, et al. Turkish FMF Study Group. Familial Mediterranean fever in Turkey: results of a nationwide multicenter study. Medicine 2005;84:1-11.
2. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
3. French FMF Consortium. A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet 1997;17:25-31.
4. International FMF consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997;90:797-807.
5. Touitou I, Lesage S, McDermott M, et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004;24:194-8. Available at: http://fmf.igh.cnrs.fr/infevers/. Accessed Oct 3, 2007.
6. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol 1998;27:92-7.
7. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227-53.
8. Livneh A, Langevitz P, Shinar Y, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999;6:1-6.
9. Balci B, Tinaztepe K, Yilmaz E, et al. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dial Transplant 2002;17:1921-3.
10. Kogan A, Shinar Y, Lidar M, et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001;102:272-6.
11. Ben-Chetrit E, Abeliovich D. The distribution of MEFV common mutations among Israeli patients with familial Mediterranean fever. Isr Med Assoc J 2003;5:592-3.
12. Shohat M, Magal N, Shohat T, et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met 694Val and amyloidosis. Eur J Hum Genet 1999;7:287-92.
13. Majeed HA, El-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum 2002;31:371-6.
14. Cazeneuve C, Sarkisian T, Pecheux C, et al. MEFV gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - genetic and therapeutic implications. Am J Hum Genet 1999;65:88-97.
15. Dewalle M, Domingo C, Rozenbaum M, et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever. Eur J Hum Genet 1998;6:95-7.
16. Yalcinkaya F, Çakar N, Misirlioglu M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatology Oxford 2000;39:67-72.
17. Pras M, Sohar E. Familial Mediterranean fever. In: Klippel JH, Dieppe PA, editors. Rheumatology. St. Louis: Mosby; 1994:3-4.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1998;16:1215.
19. Eisenberg S, Aksentijevich I, Deng Z, Kastner DL, Matzner Y. Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med 1999;129:539-42.
20. Gershoni-Baruch R, Kepten I, Shinawi M, Brik R. Direct detection of common mutations in the familial Mediterranean fever gene (MEFV) using naturally occuring and primer mediated restriction fragment analysis. Hum Mutat 1998;14:91-4.
21. Oberkanins C, Weinhausel A, Krieqshauser G, Moritz A, Kury F, Haas OA. Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips. Clin Chem 2003;49:1948-50.
22. Mattit H, Joma M, Al-Cheikh S, et al. Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet 2006;49:481-6.
23. Touitou I, Ben-Chetrit E, Notarnicola C, et al. Familial Mediterranean fever clinical and genetic features in Druzes and in Iraqi Jews: a preliminary study. J Rheumatol 1998;25:916-9.
24. Yilmaz E, Ozen S, Balci B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001;9:553-5.
25. Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: Clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999;103:e70.
26. Akar N, Misiroglu M, Yalçinkaya F, et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 1999;288:1-5.
27. Touitou I, Sarkisian T, Medlej-Hashim M, et al. International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007;56:1706-12.
28. Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001;9:634-37.
29. Konstantopoulos K, Kanta A, Deltas C, et al. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 2003;62:479-81.
30. Sarkisian T, Ajrapetyan H, Shahsuvaryan G. Molecular study of FMF patients in Armenia. Curr Drug Targets Inflamm Allergy 2005;4:113-6.
31. Gunesacar R, Kasap H, Erken E, Ozer HT. Comparison of amplification refractory mutation system and polymerase chain reaction-restriction fragment length polymorphism techniques used for the investigation of MEFV gene exon 10 point mutations in familial Mediterranean fever patients living in Cukurova region (Turkey). Genet Test 2005;9:220-5.
32. Turkcapar N, Tuncali T, Kutlay S, et al. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol Int 2007;27:545-51.
33. Ben-Chetrit E, Urieli-Shoval S, Calko S, Abeliovich D, Matzner Y Molecular diagnosis of FMF: lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol 2002;20 Suppl 26:25-9.
34. Grateau G, Pecheux C, Cazeneuve C, et al. Clinical versus genetic diagnosis of familial Mediterranean fever. QJM 2000;93:223-9.
35. Zaks N, Shinar Y, Padeh S, et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 2003;5:585-8.
36. Mansour I, Delague V, Cazeneuve C, et al. Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet 2001;9:51-5.
37. Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2003;22:339-40.
38. La Regina M, Nucera G, Diaco M, et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2003;11:50-6.
39. Cerquaglia C, La Regina M, Diaco M, et al. Geno-phenotypical correlations in Italian people afflicted with familial Mediterranean fever [abstract]. 4th International Congress on Systemic Autoinflammatory Diseases, "FMF and Beyond," 2005, Nov. 6-10, Bethesda, USA; P122.
40. Padeh S, Shinar Y, Pras E, et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 2003;30:185-90.
41. Federici L, Rittore-Domingo C, Kone-Paut I, et al. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 2006;65:1427-32.
42. Majeed HA, Al-Khateeb M, El-Shanti H, Rabaiha ZA, Tayeh M, Najib D. The spectrum of familial Mediterranean fever gene mutations in Arabs: Report of large series. Semin Arthritis Rheum 2005;34:813-8.
43. Samli H, Dogru O, Bukulmez A, Yuksel E, Ovali F, Solak M. Relationship of Tel Hashomer criteria and Mediterranean fever gene mutations in a cohort of Turkish familial Mediterranean fever patients. Saudi Med J 2006;27:1822-6.
44. Chaabouni HB, Ksantini M, M'rad R. MEFV mutations in Tunisian patients suffering from familial Mediterranean fever. Semin Arthritis Rheum 2007;36:397-401. Epub 2007 Feb 5.
45. Samuels J, Aksentijevich I, Torosyan Y. Familial Mediterranean fever at the millennium: clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998;77:268-97.
46. Tchernitchko D, Moutereau S, Legendre M, et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum 2005;52:3603-5.
47. Sarkisian TF, Ajrapetyan HS, Shahsuvaryan GR. Genetic investigations of FMF in Armenia [abstract]. 4th International Congress on Systemic Autoinflammatory Diseases, "FMF and Beyond." Nov. 6-10, 2005, Bethesda, USA; P231.
48. Tunca M, Akar S, Booth DR, et al. Familial Mediterranean fever in Western Turkey: Five year experience in one institution [abstract]. 2nd Familial Mediterranean Fever International Conference, May 3-7, 2000, Antalya, Turkey; D-2.
49. Lachmann H J, Sengul B, Yavuzsen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology Oxford 2006;45:746-50.
50. Deltas CC, Rossou E, Costi C, Mean R, Koptides M. Familial Mediterranean fever is a frequent disease among Cypriots [abstract]. 3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders. Sept 23-27, 2002, Montpellier, France; S-94.
51. Mimouni A, Magal N, Stoffman N, et al. Familial Mediterranean fever: effect of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000;105:e70.
52. Altiok O, Demirci T, Akar S, Terzioglu O, Toitou I, Tunca M. The frequency of mutations of MEFV gene in 94 Turkish FMF patients. Clin Exp Rheumatol 2002;20 Suppl 26:85.
53. Medlej-Hashim M, Serre JL, Corbani S, et al. Familial Mediterranean fever in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet 2005;48:412-20.
54. Sari I, Kirkali G, Tunca M. Comparison of phenotypes of wild-type and other genotypes of the FMF patients [abstract]. 4th International Congress on Systemic Autoinflammatory Diseases, "FMF and Beyond." Nov. 6-10, 2005, Bethesda, USA. P-221.
55. Dode C, Pecheux C, Cazeneuve C, et al. Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever. Am J Med Genet 2000;92:241-6.
56. Ayesh SK, Nassar SM, Al-Sharef WA, Abu-Libdeh BY, Darwish HM. Genetic screening of familial Mediterranean fever mutations in the Palestinian population. Saudi Med J 2005;26:732-7.
57. Oberkanins C, Weinhausel A, Kriegshauser G, Moritz A, Kury F, Haas OA. Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips. Clin Chem 2003;49:1948-50.
58. Berdeli A, Cura A, Mir S, Serdaroglu E, Özkayin N. Ailesel Akdeniz Atesli çocuklarda MEFV mutasyonlari: Ege Üniversitesi deneyimi [MEFV mutations in children with familial Mediterranean fever: experience at Ege University] (abstract). Turk Nefrol Diyal Transplant Dergisi 2003;12 Suppl 58.
59. Nucera G, Diaco M, La Regina M, Federico G, Touitou I, Manna R. Geno-phenotypical correlations in Italian people affected by familial Mediterranean fever [abstract]. 3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders. Sept 23-27, 2002, Montpellier, France; S-95.
60. Bennetts B, Oxley P, Williamson S, Roscioli T, Booth D, Christodoulou J. MEFV mutations in Australia [abstract]. 3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders. Sept 23-27, 2002, Montpellier, France; S-90.
61. Berdeli A, Mir S, Ozalkaya E, et al. MEFV gene mutation distribution in Ege region of Turkey, our single center experience [abstract]. 4th International Congress on Systemic Autoinflammatory Diseases, "FMF and Beyond." Nov. 6-10, 2005, Bethesda, USA; P-101.
62. Naman R, El-Zein C, Adib S, Medlej-Hashim M, Chouery E, Megarbane A. Familial Mediterranean fever in Lebanon: prevalence of the mutations in the different religious communities [abstract]. 3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders. Sept 23-27, 2002, Montpellier, France; S-94.
63. Shinar Y, Kogan A, Langevitz P, et al. Frequency of V726A, E148Q and M694V mutations in the MEFV gene among healthy North African and Iraq Jews [abstract]. 2nd Familial Mediterranean Fever International Conference. May 3-7, 2000, Antalya, Turkey; C-13.
64. Tunca, M, Akar S, Hawkins PN, et al. The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 2002;10:786-9.
65. Atagunduz MP, Tuglular S, Kantarci G, Akoglu E, Direskeneli H. Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis. Nephron Clin Pract 2004;96:131-5.
66. Booth DR, Lachmann HJ, Gillmore JD, Booth SE, Hawkins PN. Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. QJM 2001;94:527-31.
67. Stoffman N, Magal N, Shohat T, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000;8:307-10.
68. Gershoni-Baruch R, Shinawi M, Shamaly H, Katsinetz L, Brik R. Familial Mediterranean fever: the segregation of four different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability. Am J Med Genet 2002;109:198-201.
69. Bybee B, Booth DR, Rowazenio D, Lachmann HJ, Hawkins PN. Findings of MEFV screening program in a British centre. 3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders. Sept 23-27, 2002, Montpellier, France; S-91.
70. Yilmaz E, Balci B, Kutlay S, et al. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr 2003;45:198-202.
71. Cakar N, Yalcinkaya F, Özkaya N, et al. Familial Mediterranean fever-associated amyloidosis in childhood. Clinical features, course and outcome. Clin Exp Rheumatol 2001;19 Suppl 24:63-7.
72. Sayhan N, Ozdogan H, Kasapcopur E, et al. MEFV gene analysis in familial Mediterranean fever patients from Turkey: Prognostic value of M694V homozygous phenotype. Clin Exp Rheum 2000;18:286.
73. Delibas A, Oner A, Balci B, et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol 2005;25:434-40.